A new steroidal alkylating agent with improved activity in advanced murine leukemias P. CatsoulacosD. PolitisG. L. Wampler Original Articles Pages: 67 - 70
Ftorafur: A self-limiting source of 5-fluorouracil? L. M. van PuttenP. LelieveldF. Spreafico Original Articles Pages: 61 - 66
Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck S. DavisW. Kessler Original Articles Pages: 57 - 59
Phase-II trial of tamoxifen in advanced breast cancer R. G. WiggansP. V. WoolleyP. S. Schein Original Articles Pages: 45 - 48
Agents affecting osteolysis in patients with breast cancer R. C. CoombesA. Munro NevilleT. J. Powles Original Articles Pages: 41 - 44
Pharmacokinetics of bleomycin in man D. S. AlbertsHsiao-Sheng G. ChenS. E. Salmon Original Articles Pages: 33 - 40
Mathematical modeling —Guide to high-dose methotrexate infusion therapy S. D. Reich Original Articles Pages: 25 - 31
Antibodies as specific carriers for chemotherapeutic agents Fook H. LeeKou M. Hwang Short Review Pages: 17 - 24
Current impact of adjuvant chemotherapy in resectable cancer Anna RossiG. Bonadonna General Review Pages: 7 - 16
C.R.O.S. Conference on Combined Modalities Chemotherapy/Radiotherapy S. K. Carter Meeting Report Pages: 139 - 142
Cytotoxicity of p-chloroamphetamine in dimethylhydrazine-induced carcinomata of rat colon P. J. M. TuttonD. H. Barkla Short Communication Pages: 137 - 138
Prednimustine in adult acute myeloid leukaemia L. BrandtI. Könyves Original Articles Pages: 133 - 136
Bleomycin pharmacokinetics in man D. S. AlbertsH.-S. G. ChenJ. F. Gross Original Articles Pages: 127 - 132
Comparative metabolism and excretion of adriamycin in man, monkey, and rat P. M. WilkinsonM. IsraelE. Frei III Original Articles Pages: 121 - 125
Multiple steroid receptors in human breast cancer P. M. MartinP. H. RollandM. Toga Original Articles Pages: 115 - 120
Multiple steroid receptors in human breast cancer P. M. MartinP. H. RollandM. Toga Original Articles Pages: 107 - 113
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) A. SantoroG. Bonadonna Original Articles Pages: 101 - 105
Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity B. LantzJ. AdolfssonP. Reizenstein Original Articles Pages: 95 - 99
Physiologically based pharmacokinetic models for anticancer drugs H.-S. G. ChenJ. F. Gross General Review Pages: 85 - 94
5-Fluorouracil as adjuvant chemotherapy for large bowel cancer is it appropriate for routine community use? S. K. Carter Editorial Pages: 81 - 84
Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data A. TrouetD. Deprez-De Campeneere Daunorubicin-DNA and Doxorubicin-DNA Pages: 77 - 79
Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report G. GahrtonM. BjörkholmB. Wadman Daunorubicin-DNA in Leukemia Pages: 73 - 76
Clinical trials with daunorubincin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma A. FerrantR. HulhovenG. Sokal Daunorubicin-DNA and Adriamycin-DNA in Leukemia Pages: 67 - 71
Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease S. O. LieK. K. LieA. Glomstein Adriamycin-DNA Complex in Children Pages: 61 - 66
A survey of the anthracycline derivatives in hematology Cl. JacquillatM. WeilJ. Bernard Anthracycline Derivatives in Hematology Pages: 53 - 59
Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells C. PaulC. PetersonD. Lockner DNA-Bound Daunorubicin and Leukemic Cells Pages: 49 - 52
In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor T. Skovsgaard Daunorubicin and Daunorubicin-DNA Complex Cross Resistance Pages: 43 - 47
Distribution and metabolism of rubidazone and daunorubicin in mice R. BaurainD. Deprez-De CampeneereA. Trouet Rubidazone and Daunorubicin Pages: 37 - 41
Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes D. Deprez-De CampeneereR. BaurainA. Trouet Daunorubicin-DNA and Doxorubicin-DNA Complex Toxicity Pages: 25 - 30
Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complex M. BeranB. AnderssonH. Ehrsson Clonogenic Cells and Daunorubicin-DNA Pages: 19 - 24
Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex B. AnderssonI. AnderssonS. Eksborg Monitoring of Daunorubicin and Daunorubicinol Pages: 15 - 17
Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: Plasma levels in DBA2 mice R. BaurainD. Deprez-De CampeneereA. Trouet Daunorubicin and Doxorubicin Metabolites Pages: 11 - 14
DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro Y.-J. SchneiderR. BaurainA. Trouet DNA-Binding Parameters Pages: 7 - 10
Uptake of the daunorubicin-DNA complex in cultured fibroblasts C. PetersonG. NoëlA. Trouet Daunorubicin-DNA in Cultured Fibroblasts Pages: 3 - 6
Introduction G. GahrtonA. KillanderC. Peterson The International Symposium on the Clinical and Pharmacological Effects of the Daunorubicin-DNA Complex Huddinge University Hospital, Stockholm, Sweden, march 17, 1978 Pages: 1 - 1
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma G. MathéM. BayssasM. Hayat Short Communications Pages: 259 - 262
High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer F. A. GrecoM. F. FerR. K. Oldham Short Communications Pages: 255 - 257
Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin Aurelio Di MarcoAnna Maria CasazzaGraziella Pratesi Original Articles Pages: 249 - 254
Halomethyl-1,2,3-triazole derivatives: A new type of alkylating agent active in mouse transplantable tumors A. ContrerasRosa Ma Sánchez-PérezG. Alonso Original Articles Pages: 243 - 247
Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors V. A. LevinP. A. KabraM. A. Freeman-Dove Original Articles Pages: 233 - 242
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography F. D. JumaH. J. RogersI. D. Bradbrook Original Articles Pages: 229 - 231
Patterns of response and relapse in chemotherapy of extensive squamous carcinoma of the lung Robert B. LivingstonLance H. HeilbrunSouthwest Oncology Group Original Articles Pages: 225 - 227
The relevance of cell kinetics for optimal scheduling of 1-β-d-Arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML) M. AgliettaP. Sonneveld Original Articles Pages: 219 - 223
Cytostatic-associated vomiting effectively inhibited by domperidone (R 33 812) J. Huys Original Articles Pages: 215 - 218
